139 related articles for article (PubMed ID: 18563374)
1. [In-vivo diagnosis of malignant hyperthermia susceptibility: a microdialysis study].
Schuster F; Hager M; Metterlein T; Muellenbach RM; Wurmb T; Wunder C; Roewer N; Anetseder M
Anaesthesist; 2008 Aug; 57(8):767-74. PubMed ID: 18563374
[TBL] [Abstract][Full Text] [Related]
2. Intramuscular injection of malignant hyperthermia trigger agents induces hypermetabolism in susceptible and nonsusceptible individuals.
Metterlein T; Schuster F; Kranke P; Roewer N; Anetseder M
Eur J Anaesthesiol; 2010 Jan; 27(1):77-82. PubMed ID: 19809329
[TBL] [Abstract][Full Text] [Related]
3. The dose-response relationship and regional distribution of lactate after intramuscular injection of halothane and caffeine in malignant hyperthermia-susceptible pigs.
Schuster F; Schöll H; Hager M; Müller R; Roewer N; Anetseder M
Anesth Analg; 2006 Feb; 102(2):468-72. PubMed ID: 16428544
[TBL] [Abstract][Full Text] [Related]
4. Effects of caffeine, halothane, and 4-chloro-m-cresol on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis.
Bina S; Cowan G; Karaian J; Muldoon S; Mongan P; Bünger R
Anesthesiology; 2006 Jan; 104(1):90-100. PubMed ID: 16394695
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound Elastography for Rapid, Real-time Detection of Localized Muscular Reaction in Malignant Hyperthermia-susceptible Pigs.
Johannsen S; Türkmeneli I; Isbary S; Roewer N; Schuster F
Anesthesiology; 2018 Nov; 129(5):989-999. PubMed ID: 30204593
[TBL] [Abstract][Full Text] [Related]
6. A minimally invasive metabolic test with intramuscular injection of halothane 5 and 6 vol% to detect probands at risk for malignant hyperthermia.
Schuster F; Gardill A; Metterlein T; Kranke P; Roewer N; Anetseder M
Anaesthesia; 2007 Sep; 62(9):882-7. PubMed ID: 17697213
[TBL] [Abstract][Full Text] [Related]
7. An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot study.
Schuster F; Metterlein T; Negele S; Kranke P; Muellenbach RM; Schwemmer U; Roewer N; Anetseder M
Anesth Analg; 2008 Sep; 107(3):909-14. PubMed ID: 18713904
[TBL] [Abstract][Full Text] [Related]
8. Screening test for malignant hyperthermia in patients with persistent hyperCKemia: a pilot study.
Johannsen S; Berberich C; Metterlein T; Roth C; Reiners K; Roewer N; Schuster F
Muscle Nerve; 2013 May; 47(5):677-81. PubMed ID: 23400941
[TBL] [Abstract][Full Text] [Related]
9. Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle.
Hartung E; Koob M; Anetseder M; Schoemig P; Krauspe R; Hogrefe G; Engelhardt W
Acta Anaesthesiol Scand; 1996 Apr; 40(4):437-44. PubMed ID: 8738688
[TBL] [Abstract][Full Text] [Related]
10. Use of the caffeine-halothane contracture test for the diagnosis of malignant hyperthermia in Brazil.
Sudo RT; Cunha LB; Carmo PL; Matos AR; Trachez MM; Cardoso LA; Aguiar MI; Abreu AV; Zapata-Sudo G
Braz J Med Biol Res; 2010 Jun; 43(6):549-56. PubMed ID: 20464345
[TBL] [Abstract][Full Text] [Related]
11. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
Ording H; Bendixen D
Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
[TBL] [Abstract][Full Text] [Related]
12. Effects of the serotonin2 receptor agonist DOI on skeletal muscle specimens from malignant hyperthermia-susceptible patients.
Wappler F; Roewer N; Köchling A; Scholz J; Löscher W; Steinfath M
Anesthesiology; 1996 Jun; 84(6):1280-7. PubMed ID: 8669667
[TBL] [Abstract][Full Text] [Related]
13. Mg2+ dependence of halothane-induced Ca2+ release from the sarcoplasmic reticulum in skeletal muscle from humans susceptible to malignant hyperthermia.
Duke AM; Hopkins PM; Halsal JP; Steele DS
Anesthesiology; 2004 Dec; 101(6):1339-46. PubMed ID: 15564941
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic modulation of skeletal muscle metabolism: a microdialysis study.
Schuster F; Tas P; Müller R; Roewer N; Anetseder M
Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):372-6. PubMed ID: 16623860
[TBL] [Abstract][Full Text] [Related]
15. Sevoflurane as a potential replacement for halothane in diagnostic testing for malignant hyperthermia susceptibility: results of a preliminary study.
Metterlein T; Hartung E; Schuster F; Roewer N; Anetseder M
Minerva Anestesiol; 2011 Aug; 77(8):768-73. PubMed ID: 21730923
[TBL] [Abstract][Full Text] [Related]
16. Effects of ryanodine on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis.
Bina S; Muldoon S; Bünger R
Eur J Anaesthesiol; 2008 Jan; 25(1):48-57. PubMed ID: 17686208
[TBL] [Abstract][Full Text] [Related]
17. Abnormal action potential responses to halothane in heart muscle isolated from malignant hyperthermia-susceptible pigs.
Roewer N; Greim C; Rumberger E; Schulte am Esch J
Anesthesiology; 1995 Apr; 82(4):947-53. PubMed ID: 7717567
[TBL] [Abstract][Full Text] [Related]
18. Intramuscular injection of sevoflurane detects malignant hyperthermia predisposition in susceptible pigs.
Schuster F; Metterlein T; Negele S; Gardill A; Schwemmer U; Roewer N; Anetseder M
Anesthesiology; 2007 Oct; 107(4):616-20. PubMed ID: 17893458
[TBL] [Abstract][Full Text] [Related]
19. Patients with malignant hyperthermia demonstrate an altered calcium control mechanism in B lymphocytes.
Sei Y; Brandom BW; Bina S; Hosoi E; Gallagher KL; Wyre HW; Pudimat PA; Holman SJ; Venzon DJ; Daly JW; Muldoon S
Anesthesiology; 2002 Nov; 97(5):1052-8. PubMed ID: 12411786
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
